Name: Using Multilayered Hydrogel Bioink in Three-Dimensional Bioprinting for Homogeneous Cell Distribution (Video) | JoVE Journal
Uploaded: 2020-05-02T15:00:00.000+00:00
Duration: 6 min 29 s
Description: Learn multilayered hydrogel bioink techniques for 3D bioprinting using gelatin methacryloyl to achieve homogeneous cell distribution. This method prevents sedimentation and supports regenerative medicine applications.

ai_agent_IP

ai_agent

maintenance

instantTrialDurationMinutes

isBiopharma

enableNewMyJoveSectionDesign

educationFeatures

seoMetaApi

ai_copilot_institution_blacklist

ai_chat_institution_blacklist

freeAccessWindow

ssoRoleCapture

scheduledMaintenanceBanner

joveLabsFeatures

disable_autoplay_for_bots

extended_trial_duration

5 minutes

The authors acknowledge grants from the National Natural Science Foundation of China (81771971, 81970442, 81703470 and 81570422), National Key R&#38;D Program of China (2018YFC1005002), Science and Technology Commission of Shanghai Municipality (17JC1400200), Shanghai Municipal Science and Technology Major Project (Grant No. 2017SHZDZX01), and Shanghai Municipal Education Commission (Innovation Program 2017-01-07-00-07-E00027).

1. Preparation of cell-laden SF-GelMA
<ol>
	<li>Sterilize all the materials by using 0.22 &#956;m syringe filter units. Perform all the steps in a biological safety cabinet.</li>
	<li>Warm 1x PBS to 50 &#176;C, and dissolve gelatin in the heated 1x PBS with stirring. The final concentration of gelatin in PBS should be 10% (w/v).</li>
	<li>Add methacrylic anhydride into the gelatin solution (weight ratio of methacrylic anhydride to gelatin of 0.6 to 1) slowly with stirring, and mix the complex for at least 1 h (50 &#176;C). Typically, prepare 200 mL of 10% gelatin solution with 12 g of methacrylic anhydride; the volume depends on the needs of the study.</li>
	<li>Transfer the mixed solution containing gelatin and methacrylic anhydride to a 50 mL sterile tube.</li>
	<li>Centrifuge the mixed solution at 3,500 x g. It usually takes 3-5 min to obtain two layers. Collect the upper layer (GelMA) and discard the bottom layer (unreacted methacrylic anhydride).</li>
	<li>Dilute the upper layer solution obtained in step 1.5 with two volumes of deionized water (40&#8722;50 &#176;C).</li>
	<li>Dialyze the solution obtained in step 1.6 with a 12-14 kDa molecular weight cutoff dialysis membrane against deionized water for 5&#8722;7 days (40&#8722;50 &#176;C). Change the water twice every day.</li>
	<li>Collect and freeze the GelMA solution at &#8722;80 &#176;C overnight.</li>
	<li>Lyophilize the GelMA solution for 3&#8722;5 days in a freeze dryer with the temperature set to -45 &#176;C and the pressure set to 0.2 mbar.</li>
	<li>Dissolve the lyophilized GelMA (degree of substitution of approximately 75%) in 1x PBS containing 10% FBS (fetal bovine serum, v/v), 25 mM HEPES (N-2-hydroxyethylpiperazine-N-ethane-sulfonic acid), and photoinitiator (0.5%, w/v) to obtain the GelMA bioink preparation. 
	NOTE: The degree of substitution of GelMA can be calculated by a ninhydrin assay3.</li>
	<li>Mix the GelMA solution (10%, w/v) with different volumes of initial SF solution (5%, w/v) and different volumes of 1x PBS to obtain SF-GelMA bioinks with different concentrations of SF. The proportion per 1 mL of GelMA and SF solution in the different bioinks is presented in Table 1. 
	NOTE: All bioinks must contain a final concentration of 5% (w/v) GelMA, but the concentration of SF varies: 0.5, 0.75, 1.0, 1.25, and 1.5% (w/v) in the different SF-GelMA bioinks. Use SF-M-Layered-GelMA to term the GelMA bioink modified with SF in a layer-by-layer manner. Use SF-X-GelMA to term those GelMA modified with SF in a homogeneous manner (e.g., GelMA with modification of 1% SF was termed SF-1-GelMA).</li>
	<li>Sonicate all bioinks for 10-20 min.</li>
	<li>Grow NIH3T3 cells using DMEM (Dulbecco&#39;s modified Eagle medium) containing 10% FBS and 1% penicillin-streptomycin in an incubator (37 &#176;C with 5% CO2). Passage the cells at a ratio of 1:3 when the density reaches 80%.</li>
	<li>Centrifuge the suspension of NIH3T3 cells at 1500 rpm for 5 min. Remove the supernatant with suction and resuspend the cell pellet with fresh bioink solution in a 15 mL sterile tube. 
	NOTE: The concentration of the encapsulated cells in the bioink should be 1 x 106 cells/mL, and the concentration needs to be calculated with a cytometer.</li>
	<li>Use 2 mL of different SF-GelMA bioinks to suspend the cell pellets to obtain various cell-laden bioinks.</li>
</ol>
2. Loading, reheating and bioprinting of the SF-M-Layered-GelMA
<ol>
	<li>Load 0.4 mL of cell-laden SF-0.5-GelMA into the bottom layer of the syringe. 
	NOTE: Use a 2 mL syringe as the bioink reservoir in this study. Load different SF-GelMA bioinks into the syringe in a layer-by-layer manner.</li>
	<li>Place the syringe in ice water bath (0 &#176;C) for 5 min to cause the bottom-layer bioink to transform into a gel state.</li>
	<li>Load 0.4 mL of cell-laden SF-0.75-GelMA bioink above the bottom layer.</li>
	<li>Place the syringe with the two layers of bioinks in an ice water bath (0 &#176;C) for 5 min to cause the two layers of bioinks to transform into a gel state.</li>
	<li>Cycle the loading and cooling steps another 3 times with the remaining 3 kinds of bioinks (SF-1-GelMA, SF-1.25-GelMA, SF-1.5-GelMA) to obtain a multilayered bioink system with different concentrations of SF in the different layers. The volume used for the loading of all bioinks should be 0.4 mL.</li>
	<li>Reheat the multilayered bioink by placing the syringe in an incubator (37 &#176;C) for 30 min prior to bioprinting.</li>
	<li>Use a 2 mL syringe as the bioink reservoir with a 27 G printing nozzle. Set the speed of flow at 50 &#956;L/min, the moving speed of the nozzle at 2 mm/s, and the height of the nozzle at 1 mm. Perform the bioprinting procedure at room temperature (approximately 20 &#176;C).
	<ol>
		<li>Print the tissue construct in an extrusion manner using a custom-made bioprinter under the parameters adapted from our previous studies11,12.</li>
	</ol>
	</li>
	<li>Use ultraviolet light (365 nm, 800 mW) for 40 s to crosslink the bioprinted tissue construct.</li>
	<li>Culture the crosslinked tissue construct in DMEM (Dulbecco&#39;s modified Eagle medium) containing 10% FBS and 1% penicillin-streptomycin in an incubator (37 &#176;C with 5% CO2). The medium was changed every 8 h during the first 2 days and every 2-3 days thereafter.</li>
</ol>

<ol><li>Khademhosseini, A., Langer, R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((A+decade+of+progress+in+tissue+engineering%5BTitle%5D)+AND+%22Nature+Protocol%22%5BJournal%5D)">A decade of progress in tissue engineering.</a> Nature Protocol. 11 (10), 1775-1781 (2016).</li>
<li>Heinrich, M. A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((3D+bioprinting%3A+from+benches+to+translational+applications%5BTitle%5D)+AND+%22Small%22%5BJournal%5D)">3D bioprinting: from benches to translational applications.</a> Small. , 1805510(2019).</li>
<li>Daniela, L., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Functionalization%2C+preparation+and+use+of+cell-laden+gelatin+methacryloyl-based+hydrogels+as+modular+tissue+culture+platforms%5BTitle%5D)+AND+%22Nature+Protocols%22%5BJournal%5D)">Functionalization, preparation and use of cell-laden gelatin methacryloyl-based hydrogels as modular tissue culture platforms.</a> Nature Protocols. 11 (4), 727-746 (2016).</li>
<li>Pedde, R. D., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Emerging+biofabrication+strategies+for+engineering+complex+tissue+constructs%5BTitle%5D)+AND+%22Advanced+Materials%22%5BJournal%5D)">Emerging biofabrication strategies for engineering complex tissue constructs.</a> Advanced Materials. 29 (19), (2017).</li>
<li>Holzl, K., Lin, S., Tytgat, L., Van Vlierberghe, S., Gu, L., Ovsianikov, A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Bioink+properties+before%2C+during+and+after+3D+bioprinting%5BTitle%5D)+AND+%22Biofabrication%22%5BJournal%5D)">Bioink properties before, during and after 3D bioprinting.</a> Biofabrication. 8 (3), 032002(2016).</li>
<li>Guillotin, B., Guillemot, F. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Cell+patterning+technologies+for+organotypic+tissue+fabrication%5BTitle%5D)+AND+%22Trends+in+Biotechnology%22%5BJournal%5D)">Cell patterning technologies for organotypic tissue fabrication.</a> Trends in Biotechnology. 29 (4), 183-190 (2011).</li>
<li>Murphy, S. V., Atala, A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((3D+bioprinting+of+tissues+and+organs%5BTitle%5D)+AND+%22Nature+Biotechnology%22%5BJournal%5D)">3D bioprinting of tissues and organs.</a> Nature Biotechnology. 32, 773-785 (2014).</li>
<li>Dubbin, K., Hori, Y., Lewis, K. K., Heilshorn, S. C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Dual-stage+crosslinking+of+a+gel-phase+bioink+improves+cell+viability+and+homogeneity+for+3D+bioprinting%5BTitle%5D)+AND+%22Advanced+Healthcare+Materials%22%5BJournal%5D)">Dual-stage crosslinking of a gel-phase bioink improves cell viability and homogeneity for 3D bioprinting.</a> Advanced Healthcare Materials. 5 (19), 2488-2492 (2016).</li>
<li>Rutz, A. L., Hyland, K. E., Jakus, A. E., Burghardt, W. R., Shah, R. N. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((A+multimaterial+bioink+method+for+3D+printing+tunable%2C+cell-compatible+hydrogels%5BTitle%5D)+AND+%22Advanced+Materials%22%5BJournal%5D)">A multimaterial bioink method for 3D printing tunable, cell-compatible hydrogels.</a> Advanced Materials. 27 (9), 1607-1614 (2015).</li>
<li>Chahal, D., Ahmadi, A., Cheung, K. C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Improving+piezoelectric+cell+printing+accuracy+and+reliability+through+neutral+buoyancy+of+suspensions%5BTitle%5D)+AND+%22Biotechnology+and+Bioengineering%22%5BJournal%5D)">Improving piezoelectric cell printing accuracy and reliability through neutral buoyancy of suspensions.</a> Biotechnology and Bioengineering. 109 (11), 2932-2940 (2012).</li>
<li>Chen, N., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Hydrogel+bioink+with+multilayered+interfaces+improves+dispersibility+of+encapsulated+cells+in+extrusion+bioprinting%5BTitle%5D)+AND+%22ACS+Applied+Materials+%26+Interfaces%22%5BJournal%5D)">Hydrogel bioink with multilayered interfaces improves dispersibility of encapsulated cells in extrusion bioprinting.</a> ACS Applied Materials & Interfaces. 11, 30585-30595 (2019).</li>
<li>Zhu, K., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((A+general+strategy+for+extrusion+bioprinting+of+bio-macromolecular+bioinks+through+alginate-templated+dual-stage+crosslinking%5BTitle%5D)+AND+%22Macromolecular+Bioscience%22%5BJournal%5D)">A general strategy for extrusion bioprinting of bio-macromolecular bioinks through alginate-templated dual-stage crosslinking.</a> Macromolecular Bioscience. 18 (9), 1800127(2018).</li>
<li>Nauman, J. V., Campbell, P. G., Lanni, F., Anderson, J. L. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Diffusion+of+insulin-like+growth+factor-I+and+ribonuclease+through+fibrin+gels%5BTitle%5D)+AND+%22Biophysical+Journal%22%5BJournal%5D)">Diffusion of insulin-like growth factor-I and ribonuclease through fibrin gels.</a> Biophysical Journal. 92 (12), 4444-4450 (2007).</li>
</ol>

The authors have nothing to disclose.

The stability of the multilayered system is a key point to perform this protocol successfully. We theoretically calculated the diffusion of SF molecules in the GelMA solution based on Nauman’s study13. It was found that the diffusion of proteins in solution was related to their molecular weight. The average molecular weight (MW) of bovine serum albumin (BSA) is 66.5 kDa, and its diffusion coefficient is 64-72 μm2/s. The average MW of fibrinogen is 339.7 kDa, and its diffusion coefficien...

Three-dimensional (3D) bioprinting has been a promising method to manufacture complex architectural and functional replicas of native tissues in biofabrication and regenerative medicine1,2,3. The common strategies of bioprinting, including inkjet, extrusion, and stereolithography printing, have pros and cons from different perspectives4. Among these techniques, the extrusion procedure is most commonly used due to its cost-effectiveness. Bioink plays a key role in the process stability of extrusion bioprinting. The ideal cell-laden bioink should not only be biocompatible but also be suitable for mechanical properties5. Bioinks with low viscosity are typically presented as a liquid-like state. These bioinks can be easily and quickly deposited and avoid cell membrane damage induced by high shear stress during extrusion. However, in complex cases requiring long-term printing periods, low viscosity often gives rise to the inevitable sedimentation of the encapsulated cells in the bioink reservoir, which is usually driven by gravity and leads to an inhomogeneous cell dispersion in the bioink6,7. Consequently, a bioink with inhomogeneous cell dispersity hampers the in vitro bioprinting of a functional tissue construct.
Several recent studies focusing on bioinks have reported the promotion of homogenous dispersity of encapsulated cells. A modified alginate bioink based on dual-stage crosslinking was used for extrusion bioprinting8. An alginate polymer was modified with peptides and proteins in this study. Cells presented a more homogeneous distribution in this modified alginate than in the commonly used alginate due to the attachment sites provided by the peptides and the proteins. Alternatively, blended bioinks have been utilized to solve the sedimentation of cells in bioink. A blended bioink containing polyethylene glycol (PEG) and gelatin or gelatin methacryloyl (GelMA) with improved mechanical robustness was used in another study9. The encapsulated cells presented a homogeneous distribution mainly because the viscosity of the blended bioink was improved. In general, there are several factors influencing the dispersity of the encapsulated cells in the bioink, such as the viscosity of the bioink, the gravity of the cells, the density of the cells, and the duration of the working period. Among these factors, the gravity of cells plays a critical role in promoting sedimentation. The buoyancy and friction provided by the viscous bioink have been investigated as the main forces against gravity to date10.
Herein, we developed a novel strategy to promote homogeneous dispersity of the encapsulated cells in bioink by manipulating multiple liquid interfaces in the bioink reservoir. These liquid interfaces created by the multilayered modification of bioink can not only provide interfacial retention, which retards the sedimentation of cells, but also maintain a suitable biocompatibility and rheological behavior of the bioink. In practice, we modified aqueous GelMA solution (5%, w/v) with silk fibroin (SF) in a multilayered manner to longitudinally produce four interfaces, providing interfacial tensions in the blended bioink. As a result, the gravity loading on the cells was offset by the man-made interfacial tension, and a nearly homogeneous dispersion of the encapsulated cells in the bioink was obtained due to less sedimentation across the adjacent layers of cells. No similar protocol to slow down the sedimentation of encapsulated cells by manipulating interfacial retention in liquid bioinks has been reported to date. We present our protocol here to demonstrate a new way to solve cell sedimentation in bioprinting.

<table><tbody><tr><td>2-Hydroxy-4&amp;prime;-(2-hydroxyethoxy)-2-methylpropiophenone (PI2959)</td><td>TCI</td><td>M64BK-QD</td><td></td></tr><tr><td>4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES)</td><td>Gibco</td><td>15630080</td><td></td></tr><tr><td>Dulbecco&amp;rsquo;s modified Eagle&amp;rsquo;s medium (DMEM)</td><td>Gibco</td><td>10569044</td><td></td></tr><tr><td>fetal bovine serum (FBS)</td><td>Gibco</td><td>10091</td><td></td></tr><tr><td>Gelatin</td><td>Sigma-Aldrich</td><td>V900863MSDS</td><td></td></tr><tr><td>Methacrylic anhydride (MA)</td><td>Sigma-Aldrich</td><td>276685MSDS</td><td></td></tr><tr><td>Penicillin&amp;ndash;streptomycin antibiotics</td><td>Gibco</td><td>15140163</td><td></td></tr><tr><td>Phosphate-buffered saline (PBS)</td><td>Gibco</td><td>10010049</td><td></td></tr><tr><td>Silk fibroin</td><td>Advanced BioMatrix</td><td>5154</td><td></td></tr></tbody></table>

using multilayered hydrogel bioink in three-dimensional bioprinting for homogeneous cell distribution

Using Multilayered Hydrogel Bioink in Three-Dimensional Bioprinting for Homogeneous Cell Distribution

During the extrusion-based three-dimensional bioprinting process, liquid-like bioinks with low viscosity can protect cells from membrane damage induced by shear stress and improve the survival of the encapsulated cells. However, rapid gravity-driven cell sedimentation in the reservoir could lead to an inhomogeneous cell distribution in bioprinted structures and therefore hinder the application of liquid-like bioinks. Here, we developed a novel multilayered modified strategy for liquid-like bioinks (e.g., gelatin methacryloyl with low viscosity) to prevent the sedimentation of encapsulated cells. Multiple liquid interfaces were manipulated in the multilayered bioink to provide interfacial retention. Consequently, the cell sedimentation action going across adjacent layers in the multilayered system was retarded in the bioink reservoir. It was found that the interfacial retention was much higher than the sedimental pull of cells, demonstrating a critical role of the interfacial retention in preventing cell sedimentation and promoting a more homogeneous dispersion of cells in the multilayered bioink.

A schematic of the preparation of cell-laden bioinks is shown in Figure 1. After preparation of the different bioinks, loading, reheating and bioprinting were performed (Figure 2). To evaluate the distribution of the encapsulated cells in the bioink reservoir, a bioprinting procedure was performed using three different cell-laden bioinks in three 96-well plates (Figure 3A). Two control groups (pristine GelMA and SF-1-GelMA bioinks) ...

Here, we developed a novel multilayered modified strategy for liquid-like bioinks (gelatin methacryloyl with low viscosity) to prevent the sedimentation of encapsulated cells.

During the extrusion-based three-dimensional bioprinting process, liquid-like bioinks with low viscosity can protect cells from membrane damage induced by ...

using-multilayered-hydrogel-bioink-three-dimensional-bioprinting-for

Research

JoVE Journal

Bioengineering

A bioprinter was used to create patterned hydrogels based on a sacrificial mold.  The poloxamer mold was backfilled with a second hydrogel and then eluted, leaving voids which were filled with a third hydrogel. This method uses fast elution and good printability of poloxamer to generate complex architectures from biopolymers.

Printing Thermoresponsive Reverse Molds for the Creation of Patterned Two-component Hydrogels for 3D Cell Culture

A Cartesian bioprinter was designed and fabricated to allow multi-material deposition in precise, reproducible geometries, while also allowing control of environmental factors. Utilizing the three-dimensional bioprinter, complex and viable constructs may be printed and easily reproduced.

Viability of Bioprinted Cellular Constructs Using a Three Dispenser Cartesian Printer

We describe a set of protocols that together provide a tissue-mimicking hydrogel bioink with which functional and viable 3-D tissue constructs can be bioprinted for use in in vitro screening applications.

Bioprinting Cellularized Constructs Using a Tissue-specific Hydrogel Bioink

This protocol describes a bioprinting methodology using an automated robotic depositing system that incorporates etched topographical guidance cues with the precision deposition of a cell bearing hydrogel bioink. The printed cells are directly delivered to the etched features and are able to sense and orientate with them.

Automated Robotic Dispensing Technique for Surface Guidance and Bioprinting of Cells

We provide a generalized protocol based on a microfluidic bioprinting strategy for engineering a microfibrous vascular bed, where a secondary cell type could be further seeded into the interstitial space of this microfibrous structure to generate vascularized tissues and organoids.

Microfluidic Bioprinting for Engineering Vascularized Tissues and Organoids

We developed a heterogeneous breast cancer model consisting of immortalized tumor and fibroblast cells embedded in a bioprintable alginate/gelatin bioink. The model recapitulates the in vivo tumor microenvironment and facilitates the formation of multicellular tumor spheroids, yielding insight into the mechanisms driving tumorigenesis.

Bioprintable Alginate/Gelatin Hydrogel 3D In Vitro Model Systems Induce Cell Spheroid Formation

This article describes a method of transforming a low-cost commercial 3D printer into a bacterial 3D printer that can facilitate printing of patterned biofilms. All necessary aspects of preparing the bioprinter and bio-ink are described, as well as verification methods to assess the formation of biofilms.

Three-dimensional Patterning of Engineered Biofilms with a Do-it-yourself Bioprinter

Presented here is a method for the 3D bioprinting of gelatin methacryloyl.

Protocols of 3D Bioprinting of Gelatin Methacryloyl Hydrogel Based Bioinks

This protocol highlights a method to rapidly assess the biocompatibility of a crystalline nanocellulose (CNC)/agarose composite hydrogel biomaterial ink with mouse bone marrow-derived mast cells in terms of cell viability and phenotypic expression of the cell surface receptors, Kit (CD117) and high-affinity IgE receptor (FcεRI).

Fabrication of a Crystalline Nanocellulose Embedded Agarose Biomaterial Ink for Bone Marrow-Derived Mast Cell Culture

This article describes how to 3D bioprint phototunable hydrogels to study extracellular matrix stiffening and fibroblast activation.

3D Bioprinting Phototunable Hydrogels to Study Fibroblast Activation

This study introduces a novel κ-carrageenan sub-microgel suspension bath, displaying remarkable reversible jamming-unjamming transition properties. These attributes contribute to the construction of biomimetic tissues and organs in embedded 3D bioprinting. The successful printing of heart/esophageal-like tissues with high resolution and cell growth demonstrates high-quality bioprinting and tissue engineering applications.

Embedded Bioprinting of Tissue-like Structures Using &#954;-Carrageenan Sub-Microgel Medium

Learn multilayered hydrogel bioink techniques for 3D bioprinting using gelatin methacryloyl to achieve homogeneous cell distribution. This method prevents sedimentation and supports regenerative medicine applications.

Using Multilayered Hydrogel Bioink in Three-Dimensional Bioprinting for Homogeneous Cell Distribution

Explore More Videos